˹. (OPK) Press Releases /investors/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_b4e6ff6ef47dceb9694bce8228582222/opko/files/theme/images/logo-sm.png ˹. Logo /investors Equisolve Investor Relations Suite <![CDATA[˹ Reports First Quarter 2024 Business Highlights and Financial Results]]> /investors/news-events/press-releases/detail/499/opko-health-reports-first-quarter-2024-business-highlights-and-financial-results Tue, 07 May 24 16:05:00 -0400 /investors/news-events/press-releases/detail/499/opko-health-reports-first-quarter-2024-business-highlights-and-financial-results <![CDATA[˹ to Report First Quarter 2024 Financial Results on May 7, 2024]]> /investors/news-events/press-releases/detail/498/opko-health-to-report-first-quarter-2024-financial-results-on-may-7-2024 Fri, 03 May 24 08:00:00 -0400 /investors/news-events/press-releases/detail/498/opko-health-to-report-first-quarter-2024-financial-results-on-may-7-2024 <![CDATA[Labcorp Announces Acquisition of Select Assets of BioReference Health’s Diagnostics Business]]> /investors/news-events/press-releases/detail/497/labcorp-announces-acquisition-of-select-assets-of-bioreference-healths-diagnostics-business Thu, 28 Mar 24 08:55:00 -0400 /investors/news-events/press-releases/detail/497/labcorp-announces-acquisition-of-select-assets-of-bioreference-healths-diagnostics-business <![CDATA[AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV]]> /investors/news-events/press-releases/detail/496/aids-clinical-trial-group-presents-results-from-phase-1-study-of-modex-trispecific-antibody-for-the-treatment-and-prevention-of-hiv Tue, 05 Mar 24 08:52:00 -0500 /investors/news-events/press-releases/detail/496/aids-clinical-trial-group-presents-results-from-phase-1-study-of-modex-trispecific-antibody-for-the-treatment-and-prevention-of-hiv <![CDATA[˹ Reports Fourth Quarter 2023 Business Highlights and Financial Results]]> /investors/news-events/press-releases/detail/495/opko-health-reports-fourth-quarter-2023-business-highlights-and-financial-results Tue, 27 Feb 24 16:05:00 -0500 /investors/news-events/press-releases/detail/495/opko-health-reports-fourth-quarter-2023-business-highlights-and-financial-results <![CDATA[˹ to Report Fourth Quarter 2023 Financial Results on February 27, 2024]]> /investors/news-events/press-releases/detail/494/opko-health-to-report-fourth-quarter-2023-financial-results-on-february-27-2024 Thu, 22 Feb 24 16:05:00 -0500 /investors/news-events/press-releases/detail/494/opko-health-to-report-fourth-quarter-2023-financial-results-on-february-27-2024 <![CDATA[˹ Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes]]> /investors/news-events/press-releases/detail/493/opko-health-announces-closing-of-private-offering-of-230-million-convertible-senior-notes-due-2029-including-full-exercise-of-initial-purchasers-option-to-purchase-additional-notes Tue, 09 Jan 24 16:05:00 -0500 /investors/news-events/press-releases/detail/493/opko-health-announces-closing-of-private-offering-of-230-million-convertible-senior-notes-due-2029-including-full-exercise-of-initial-purchasers-option-to-purchase-additional-notes <![CDATA[˹ to Present at the 42nd Annual J.P. Morgan Healthcare Conference]]> /investors/news-events/press-releases/detail/492/opko-health-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference Mon, 08 Jan 24 08:00:00 -0500 /investors/news-events/press-releases/detail/492/opko-health-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference <![CDATA[˹ Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029]]> /investors/news-events/press-releases/detail/491/opko-health-announces-pricing-of-private-offering-of-200-million-convertible-senior-notes-due-2029 Thu, 04 Jan 24 23:31:00 -0500 /investors/news-events/press-releases/detail/491/opko-health-announces-pricing-of-private-offering-of-200-million-convertible-senior-notes-due-2029 <![CDATA[˹ Announces Private Offering of Convertible Senior Notes Due 2029]]> /investors/news-events/press-releases/detail/490/opko-health-announces-private-offering-of-convertible-senior-notes-due-2029 Wed, 03 Jan 24 17:05:00 -0500 /investors/news-events/press-releases/detail/490/opko-health-announces-private-offering-of-convertible-senior-notes-due-2029